FAC Explorer

Audit 28215

FY End
2022-06-30
Total Expended
$3.52M
Findings
4
Programs
6
Organization: Heritage Health and Housing, Inc. and Subsidiaries (NY)
Year: 2022 Accepted: 2023-06-11
Auditor: Padilla and Company LLP

Organization Exclusion Status:

Findings

ID Ref Severity Repeat Requirement
28543 2022-001 Significant Deficiency - L
28544 2022-001 Significant Deficiency - L
604985 2022-001 Significant Deficiency - L
604986 2022-001 Significant Deficiency - L

Programs

ALN Program Spent Major Findings
93.527 Affordable Care Act (aca) Grants for New and Expanded Services Under the Health Center Program $1.77M Yes 1
93.224 Consolidated Health Centers (community Health Centers, Migrant Health Centers, Health Care for the Homeless, and Public Housing Primary Care) $915,982 Yes 1
32.006 Covid-19 Telehealth Program $463,102 - 0
14.195 Section 8 Housing Assistance Payments Program $306,745 Yes 0
93.994 Maternal and Child Health Services Block Grant to the States $46,252 - 0
93.268 Immunization Cooperative Agreements $24,168 - 0

Contacts

Name Title Type
T8F4YC74ZPR3 Douglas Blomberg Auditee
2128620054 Jose Paolo Espiritu Auditor
No contacts on file

Notes to SEFA

Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, Audit of States, Local Governments and Not for Profit Organizations whereincertain types of expenditures are not allowable or are limited as to reimbursement. De Minimis Rate Used: N Rate Explanation: The auditee did not use the de minimis cost rate.

Finding Details

Finding 2022-001
The Organization was not able to submit FFR or SF-425 on or before the deadline.
Finding 2022-001
The Organization was not able to submit FFR or SF-425 on or before the deadline.
Finding 2022-001
The Organization was not able to submit FFR or SF-425 on or before the deadline.
Finding 2022-001
The Organization was not able to submit FFR or SF-425 on or before the deadline.